MedPath
HSA Approval

MYUNG IN HALOPERIDOL INJECTION 5 mg/ml

SIN11225P

MYUNG IN HALOPERIDOL INJECTION 5 mg/ml

MYUNG IN HALOPERIDOL INJECTION 5 mg/ml

November 15, 1999

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAMUSCULAR

Medical Information

N05AD01

haloperidol

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

MYUNG IN PHARM CO LTD

Active Ingredients

HALOPERIDOL

5 mg/ml

Haloperidol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MYUNG IN HALOPERIDOL INJECTION 5 mg/ml - HSA Approval | MedPath